According to the announcement of Bgi Genomics Co.Ltd(300676) , the meeting of the board of directors and the meeting of the board of supervisors of the company respectively considered and approved the proposal on adjusting the scheme of repurchasing the company’s shares by means of centralized bidding in 2021, and agreed to adjust the scheme of repurchasing the company’s shares by means of centralized bidding in 2021. The total amount of the repurchase fund is adjusted from not less than 130 million yuan and not more than 260 million yuan to not less than 260 million yuan and not more than 520 million yuan; The upper limit of share repurchase price remains unchanged at no more than 130 yuan / share, and the number of shares repurchased shall be adjusted accordingly according to the upper limit of the repurchase price.
© China Stock Market News